article thumbnail

MIT unlocks real-time powder particle size distribution monitoring

European Pharmaceutical Review

Researchers have developed a physics-enhanced autocorrelation-based estimator (PEACE) machine learning algorithm that can extract the particle size distribution (PSD) of a pharmaceutical powder surface from its laser speckle. This limits its application to surfaces encountered in pharmaceuticals manufacturing.

article thumbnail

Innovative radioligand manufacturing facility inaugurated

European Pharmaceutical Review

The first industrial-scale pharmaceutical manufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. Orano Med stated that ATLab Indianapolis represents a $20 million investment. The facility has over 30,000 ft² of floor space. The company hopes to produce this number tenfold by the end of 2030.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

WuXi STA breaks ground on new Delaware manufacturing facility

European Pharmaceutical Review

Contract research, development and manufacturing organisation (CRDMO) WuXi STA has broken ground on its new 190-acre pharmaceutical manufacturing campus in Middletown, Delaware, US. The biopharmaceutical industry is part of Delaware’s DNA,” stated Delaware Governor John Carney.

article thumbnail

Fair Market Value vs. Current Market Leverage

Pharmaceutical Commerce

How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services

article thumbnail

Fair Market Value vs. Current Market Leverage

PharmExec

How pharmaceutical manufacturers should consider their Fair Market Value cost assessment compared to their negotiation leverage when contracting for distribution services

article thumbnail

Vaccine producers promise equal access in future pandemics

European Pharmaceutical Review

Three trade bodies representing vaccine creators and manufacturers are endorsing The Berlin Declaration framework , a proposal that outlines how the industry would reserve an allocation of real-time vaccine production for swift distribution to priority populations in lower-income countries in future pandemics.

article thumbnail

Novel two-chamber setup could predict HPAPI dustiness

European Pharmaceutical Review

Processes in pharmaceutical manufacturing such as processing, milling, grinding, and mixing, are associated with the generation of dust. A further aim of this study was to confirm that the newly developed TCS ensured a reproducible and precise dustiness investigation of pharmaceutical powders.